Citation Impact
Citing Papers
The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies
2011
Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model
2014
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Significance of Azole Antifungal Drug Cross-Resistance in Candida glabrata
2006
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Voriconazole Prophylaxis in Lung Transplant Recipients
2006
Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin
2007
Vulvovaginal candidosis
2007 Standout
Spatial and temporal analyses to investigate infectious disease transmission within healthcare settings
2014
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
2005 Standout
CYTOMEGALOVIRUS INFECTION AND PROGRESSION TOWARDS AIDS IN HAEMOPHILIACS WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION
1989
Viral Respiratory Tract Infections in Transplant Patients
2007
Antecedent- and response-focused emotion regulation: Divergent consequences for experience, expression, and physiology.
1998 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients
2007
Prevention and Treatment of Respiratory Syncytial Virus and Parainfluenza Viruses in Immunocompromised Patients
1997
Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases
2014
INFECTIONS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION
2001
Epidemiology and Prevention of Pediatric Viral Respiratory Infections in Health-Care Institutions
2001
Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: Focus on community respiratory virus infections
2001
Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
2001
Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient
2007
Parainfluenza Virus 3 Infection after Stem Cell Transplant: Relevance to Outcome of Rapid Diagnosis and Ribavirin Treatment
2001
Nosocomial Respiratory Syncytial Virus Infections Prevention and Control in Bone Marrow Transplant Patients
1997
The Burden of Respiratory Syncytial Virus Infection in Young Children
2009 Standout
The disclosure processes model: Understanding disclosure decision making and postdisclosure outcomes among people living with a concealable stigmatized identity.
2010 Standout
Respiratory Syncytial Virus Infection in Patients with Hematological Diseases: Single-Center Study and Review of the Literature
2007
Respiratory virus shedding in exhaled breath and efficacy of face masks
2020 Standout
Infection Control of Nosocomial Respiratory Viral Disease in the Immunocompromised Host
1997
Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus
1998
HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene
1998 StandoutNobel
Coronavirus as a possible cause of severe acute respiratory syndrome
2003 Standout
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Aerosol Generating Procedures and Risk of Transmission of Acute Respiratory Infections to Healthcare Workers: A Systematic Review
2012 Standout
Prevention and Treatment of Influenza in Immunocompromised Patients
1997
Improving Influenza Immunization Rates Among Healthcare Workers Caring for High-Risk Pediatric Patients
2004
Transmission of Influenza: Implications for Control in Health Care Settings
2003
Antivirals and resistance: influenza virus
2011
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
The Changing Face of Fungal Infections in Health Care Settings
2005
Respiratory Consequences of Rhinovirus Infection
2003
Antifungal Agents for Secondary Prophylaxis Based on Response to Initial Antifungal Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Prior Pulmonary Aspergillosis
2014
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Linguistic predictors of adaptive bereavement.
1997 Standout
Current Treatment Strategies for Disseminated Candidiasis
2005
Community Respiratory Virus Infections in Immunocompromised Patients with Cancer
1997
Emerging Fungal Diseases
2005
Emotional disclosure through writing or speaking modulates latent Epstein-Barr virus antibody titers.
1994
Active surveillance for respiratory virus infections in adults who have undergone bone marrow and peripheral blood stem cell transplantation
2003
Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations
2006
Coronavirus 229E-Related Pneumonia in Immunocompromised Patients
2003
New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies
2006
Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients
2011
Treatment of picornavirus infections
2002
Prevention and Early Treatment of Invasive Fungal Infection in Patients with Cancer and Neutropenia and in Stem Cell Transplant Recipients in the Era of Newer Broad-Spectrum Antifungal Agents and Diagnostic Adjuncts
2007
Infections in Patients with Multiple Myeloma in the Era of High‐Dose Therapy and Novel Agents
2009
A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response
2016 StandoutNobel
Nosocomial infections in patients with cancer
2009
Identification of a new human coronavirus
2004 Standout
Randomized Controlled Multicenter Trial of Aerosolized Ribavirin for Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic Cell Transplant Recipients
2006
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
A newly discovered human pneumovirus isolated from young children with respiratory tract disease
2001 Standout
Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial
1999 Standout
Rhinovirus and the lower respiratory tract
2004
Changing face of health-care associated fungal infections
2005
Non‐comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation
2006
Advances and challenges in management of invasive mycoses
2005
Respiratory Viral Infections in Adults With Hematologic Malignancies and Human Stem Cell Transplantation Recipients
2006
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
1995 Standout
Infection in Solid-Organ Transplant Recipients
2007 Standout
Respiratory syncytial virus infection following hematopoietic stem cell transplantation
2002
Respiratory Syncytial Virus and Parainfluenza Virus
2001
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Herpes Zoster
2013 Standout
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
2003 Standout
Experimental disclosure and its moderators: A meta-analysis.
2006 Standout
Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses
2009
Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro
2003
Infection in Organ-Transplant Recipients
1998 Standout
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
2020 Standout
Candida glabrata Fungemia in Transplant Patients Receiving Voriconazole after Fluconazole
2005
Respiratory Syncytial Virus Infection among Intubated Adults in a University Medical Intensive Care Unit
1991
Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria
2011
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Guideline for Prevention of Nosocomial Pneumonia
1994
Issues Related to the Design and Interpretation of Clinical Trials of Salvage Therapy for Invasive Mold Infection
2006
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Making sense of the meaning literature: An integrative review of meaning making and its effects on adjustment to stressful life events.
2010 Standout
Management and Prevention of Cytomegalovirus Infection After Renal Transplantation
1992
Molecular Epidemiology of Two Consecutive Outbreaks of Parainfluenza 3 in a Bone Marrow Transplant Unit
1998
Nosocomial Respiratory Syncytial Virus Infections: Prevention and Control in Bone Marrow Transplant Patients
1997
Invasive Fungal Pathogens: Current Epidemiological Trends
2006
Prevention and Treatment of Cancer-Related Infections
2012
Herpesviruses as Co-Factors of HIV Disease: Case not Proven
1995
Respiratory Viruses Other than Influenza Virus: Impact and Therapeutic Advances
2008
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients
2013
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Control of Influenza A on a Bone Marrow Transplant Unit
2000
Respiratory Syncytial Virus Infection: Immune Response, Immunopathogenesis, and Treatment
1999
AspergillusInfections in Transplant Recipients
2005
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans
2009 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Spectrum of Clinical Illness in Hospitalized Patients with "Common Cold" Virus Infections
2000
Respiratory Syncytial Virus Infection in Adults
2000
Voriconazole Therapeutic Drug Monitoring
2006
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Receptor Binding and Membrane Fusion in Virus Entry: The Influenza Hemagglutinin
2000 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Emotional repression, stress disclosure responses, and Epstein-Barr viral capsid antigen titers.
1990
The Risk of Determining Risk with Multivariable Models
1993 Standout
Polyoxometalates in Medicine
1998 Standout
CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and Disease
1999 Standout
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Antimicrobial strategies in the care of organ transplant recipients
1993
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome
2001
Respiratory Syncytial Virus Infection in Adults
2000
Respiratory Virus Infections in Adults with Hematologic Malignancies: A Prospective Study
2003
The Biology of Chemokines and their Receptors
2000 Standout
Multiple Myeloma
2011 Standout
Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection
2007
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Identification of a Chemokine Receptor Encoded by Human Cytomegalovirus as a Cofactor for HIV-1 Entry
1997 Science
Human metapneumovirus: a not so new virus
2004
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2013
Diagnosis of Respiratory Syncytial Virus Infection: Comparison of Reverse Transcription-PCR to Viral Culture and Serology in Adults with Respiratory Illness
2002
Works of J. A. Englund being referenced
Community Respiratory Virus Infections Among Hospitalized Adult Bone Marrow Transplant Recipients
1996
Prevalence of cytomegalovirus antibody in hemophiliacs and homosexuals infected with human immunodeficiency virus type 1
1988
The many faces of Epstein-Barr virus
1988
Breakthrough Fungal Infections in Stem Cell Transplant Recipients Receiving Voriconazole
2004
Safety and Tolerability of Oseltamivir Prophylaxis in Hematopoietic Stem Cell Transplant Recipients: A Retrospective Case-Control Study
2007
Respiratory Disease Due to Parainfluenza Virus in Adult Bone Marrow Transplant Recipients
1996
Rhinovirus Infections in Myelosuppressed Adult Blood and Marrow Transplant Recipients
1999
Nosocomial transmission of respiratory syncytial virus in immunocompromised adults
1991
Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.
1995
Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipients
1991